Nuvalent Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Nuvalent Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvalent Inc - Ordinary Shares - Class A
Rating: 1.26016675
Author: Trendlyne DVM scores

about

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that ...

76.58 0.56 (0.74%)

32.53% Fall from 52W High

418.4K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Nuvalent Inc - Ordinary Shares - Class A is on 04 Sep 2025 for the purpose of Cantor Global Healthcare Conference 2025 See details